Our Work - Public Health and Science
TweetPOGO is working to improve transparency and accountability at the Food and Drug Administration and other federal agencies in charge of protecting public health. POGO also works to ensure that science is the basis for public policy decisions rather than the undue influence of special interests.
Podcast: Crash Course?
May 9, 2011
Concerns About Potential Conflicts of Interest, Patient Safety Cited in Shut Down of Stanford Clinical Trial, According to Emails
January 13, 2011
Obama Administration Should Re-Open Investigation of FDA Wrongdoing After Inspector General Office Rejected Whistleblower Complaints
January 13, 2011
POGO Asks DHHS Secretary Sebelius to Reinvestigate FDA's Negligent Oversight of Unsafe Medical Devices
January 12, 2011
POGO's fourth reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 23, 2010
POGO's third reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 16, 2010
POGO's second reply to letter from Dr. Schatzberg and Dr. Nemeroff
December 9, 2010
POGO's first reply to letters from Dr. Schatzberg and Dr. Nemeroff
December 8, 2010
POGO Letter to NIH on Ghostwriting Academics
November 29, 2010
POGO Letter to NIH Director Francis Collins Again Urges Public Disclosure of Medical Researchers' Financial Ties to Industry
November 19, 2010
POGO Letter to FDA Commissioner Margaret Hamburg Regarding Potentially Dangerous Drug Interaction Invovling Seroquel and Methadone
October 25, 2010
POGO's letter to Deputy HHS IG on FDA's CDRH's low standard of medical devices approval
September 28, 2010
The Finances Of FDA Advisory Committee Members: If Information Must Be Withheld, Let It Be Done Openly
August 16, 2010
POGO Letter To NIH Director: Medical Researchers Should Be Made To Publicly Disclose Possible Conflicts Of Interest
March 15, 2010
POGO Letter To NIH Director Francis Collins Urges Public Disclosure of Medical Researchers' Financial Ties To Industry
March 11, 2010
